CR9468A - Oblea que contiene hormonas esteroides - Google Patents

Oblea que contiene hormonas esteroides

Info

Publication number
CR9468A
CR9468A CR9468A CR9468A CR9468A CR 9468 A CR9468 A CR 9468A CR 9468 A CR9468 A CR 9468A CR 9468 A CR9468 A CR 9468A CR 9468 A CR9468 A CR 9468A
Authority
CR
Costa Rica
Prior art keywords
steroid hormones
oblea
containing steroid
dissolved
released
Prior art date
Application number
CR9468A
Other languages
English (en)
Spanish (es)
Inventor
Krumme Markus
Radlmaier Albert
General Sascha
Dittgen Michael
Jensen Keith
Original Assignee
Bayer Shering Pharma Ag
Lts Lohman Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36998911&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9468(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Shering Pharma Ag, Lts Lohman Therapie Systeme Ag filed Critical Bayer Shering Pharma Ag
Publication of CR9468A publication Critical patent/CR9468A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CR9468A 2005-03-31 2007-10-23 Oblea que contiene hormonas esteroides CR9468A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005015128A DE102005015128B4 (de) 2005-03-31 2005-03-31 Wafer enthaltend Steroidhormone

Publications (1)

Publication Number Publication Date
CR9468A true CR9468A (es) 2008-01-21

Family

ID=36998911

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9468A CR9468A (es) 2005-03-31 2007-10-23 Oblea que contiene hormonas esteroides

Country Status (26)

Country Link
US (2) US9763960B2 (cg-RX-API-DMAC7.html)
EP (1) EP1863444B1 (cg-RX-API-DMAC7.html)
JP (2) JP5843416B2 (cg-RX-API-DMAC7.html)
KR (2) KR101428625B1 (cg-RX-API-DMAC7.html)
CN (2) CN101132766A (cg-RX-API-DMAC7.html)
AR (1) AR054245A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006228820B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0609601A2 (cg-RX-API-DMAC7.html)
CA (1) CA2598892C (cg-RX-API-DMAC7.html)
CR (1) CR9468A (cg-RX-API-DMAC7.html)
DE (1) DE102005015128B4 (cg-RX-API-DMAC7.html)
DO (1) DOP2006000070A (cg-RX-API-DMAC7.html)
EA (1) EA014183B1 (cg-RX-API-DMAC7.html)
GT (1) GT200600126A (cg-RX-API-DMAC7.html)
IL (1) IL186081A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007012081A (cg-RX-API-DMAC7.html)
NO (1) NO20075404L (cg-RX-API-DMAC7.html)
NZ (1) NZ592882A (cg-RX-API-DMAC7.html)
PE (1) PE20061194A1 (cg-RX-API-DMAC7.html)
SG (1) SG179459A1 (cg-RX-API-DMAC7.html)
SV (1) SV2008002466A (cg-RX-API-DMAC7.html)
TW (1) TWI393576B (cg-RX-API-DMAC7.html)
UA (1) UA92011C2 (cg-RX-API-DMAC7.html)
UY (1) UY29441A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006102990A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200706116B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
AU2006236564B2 (en) 2005-04-15 2011-02-17 Besins Healthcare Luxembourg S.A.R.L. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
BRPI0908231A2 (pt) * 2008-02-13 2015-07-21 Bayer Schering Pharma Akltiengesellschaft Sistema de liberação de fármaco com efeito estabilizante
KR20100125309A (ko) * 2008-02-13 2010-11-30 바이엘 쉐링 파마 악티엔게젤샤프트 에스트라디올-함유 약물 전달 시스템
TW201008569A (en) * 2008-08-08 2010-03-01 Bayer Schering Pharma Ag Progestin-containing drug delivery system
JP2012509286A (ja) * 2008-11-21 2012-04-19 バイエル ファーマ アクチエンゲゼルシャフト 薬物送達システム
JP5777170B2 (ja) 2009-10-30 2015-09-09 アイエックス バイオファーマ リミテッド 速溶性固体剤形
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
WO2014018075A1 (en) 2012-07-23 2014-01-30 Crayola, Llc Dissolvable films and methods of using the same
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
SG11202007303YA (en) * 2018-02-02 2020-08-28 Aytu Bioscience Inc Methods of testosterone therapy

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
WO1993023011A1 (en) * 1992-05-18 1993-11-25 Minnesota Mining And Manufacturing Company Transmucosal drug delivery device
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19847252B4 (de) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
EP1296653A4 (en) * 2000-07-06 2005-09-21 Sarnoff Corp METHOD FOR FORMULATING HYGIENE PRODUCTS WITH IMPROVED STABILITY
WO2005039531A1 (en) * 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
GB0100760D0 (en) * 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
JP2007512225A (ja) * 2003-07-31 2007-05-17 アイバックス コーポレイション 脳標的ステロイド薬剤供給系用の経粘膜剤形

Also Published As

Publication number Publication date
MX2007012081A (es) 2007-11-21
KR101428625B1 (ko) 2014-08-13
CA2598892A1 (en) 2006-10-05
EP1863444B1 (de) 2015-12-09
NZ592882A (en) 2012-12-21
BRPI0609601A2 (pt) 2010-04-20
CN104983669B (zh) 2018-05-18
EA200702102A1 (ru) 2008-04-28
US20060222708A1 (en) 2006-10-05
AR054245A1 (es) 2007-06-13
SV2008002466A (es) 2008-02-08
NO20075404L (no) 2007-12-20
JP2013155190A (ja) 2013-08-15
US9763960B2 (en) 2017-09-19
US20170348321A1 (en) 2017-12-07
UY29441A1 (es) 2006-10-31
DE102005015128B4 (de) 2008-12-11
IL186081A0 (en) 2008-01-20
TWI393576B (zh) 2013-04-21
GT200600126A (es) 2007-03-14
TW200714299A (en) 2007-04-16
EA014183B1 (ru) 2010-10-29
DOP2006000070A (es) 2007-08-15
UA92011C2 (ru) 2010-09-27
WO2006102990A2 (de) 2006-10-05
EP1863444A2 (de) 2007-12-12
PE20061194A1 (es) 2006-11-23
WO2006102990A3 (de) 2007-03-22
AU2006228820B2 (en) 2011-08-25
CN104983669A (zh) 2015-10-21
AU2006228820A1 (en) 2006-10-05
KR20140063740A (ko) 2014-05-27
KR20080002798A (ko) 2008-01-04
JP5843416B2 (ja) 2016-01-13
DE102005015128A1 (de) 2006-10-05
SG179459A1 (en) 2012-04-27
CN101132766A (zh) 2008-02-27
ZA200706116B (en) 2008-11-26
JP2008534533A (ja) 2008-08-28
CA2598892C (en) 2014-10-14

Similar Documents

Publication Publication Date Title
CR9468A (es) Oblea que contiene hormonas esteroides
AR059174A1 (es) Formas farmaceuticas en forma de pelicula para usar en la cavidad bucal (obleas)
EA200870219A1 (ru) Стабилизированные сукцинатом витамина е фармацевтические композиции, способы их получения и применения
GT200500045A (es) Solidos supersaturados estabilizados de drogas lipofilicas
AR059358A1 (es) Formulaciones farmaceuticas
NI201000183A (es) Regímenes de dosificación de antiprogestina.
CR20140340A (es) Formas farmacéuticas de dosificación oral resistente a interferencias que comprenden un analgésico opioide
EA201070568A1 (ru) Фармацевтические составы
GT200500155A (es) Terapia del càncer resistente al platino
AU2008347158A8 (en) Oral pharmaceutical dosage forms
MX2013011336A (es) Composiciones farmaceuticas intranasales de benzodiazepina.
ATE536865T1 (de) Sublinguale brausetablette aus progesteron zusammen mit cyclodextrin
CR11078A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas
ECSP10010588A (es) Formulacion de medicamento solida con liberacion retardada
UY29395A1 (es) Formulación de medicamentos conteniendo vardenafilo.
EA201171497A1 (ru) Снижение флуктуаций опиоидов в крови
AR092840A1 (es) Elaboracion de degarelix
UY31128A1 (es) Formulacion de nevirapina de liberacion prolongada
CR10407A (es) Formulacion de medicamento liquida.
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
EA201170843A1 (ru) Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью
CO6331424A2 (es) Formulacion farmaceutica de eprosartan
PE20151432A1 (es) Formulaciones de lorazepam de liberacion sostenida
CU23641B7 (es) Oblea que contiene hormonas esteroides
AR064419A1 (es) Composiciones farmaceuticas